KUDO BIOTECHNOLOGY Trademark
Trademark Overview
On Monday, July 3, 2023, a trademark application was filed for KUDO BIOTECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the KUDO BIOTECHNOLOGY trademark a serial number of 98069328. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, October 28, 2024. This trademark is owned by RVAC Medicines Pte. Ltd.. The KUDO BIOTECHNOLOGY trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacturing of pharmaceuticals, biological preparations and drug conjugates; custom assembly of pharmaceuticals, biological preparations and drug conjugates; custom manufacturing of pharmaceuticals; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates
Pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemico-pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; drugs for medical purposes, namely, anticancer preparations; biological preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicinal preparations for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; pharmaceutical preparations, substances and compositions for the prevention of cancer, infectious disease, metabolic disease, and central nervous system disease and conditions
Scientific and engineering research services relating to the manufacture of biotechnology and pharmaceutical products; development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagents, pharmaceutical formulations, and biologics; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of nucleic acid medicines; research and development of mRNA drug substance and drug products; biomedical research services; development of pharmaceutical preparations and medicines
General Information
| Serial Number | 98069328 |
| Word Mark | KUDO BIOTECHNOLOGY |
| Filing Date | Monday, July 3, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, October 28, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 31, 2024 |
Trademark Statements
| Goods and Services | Custom manufacturing of pharmaceuticals, biological preparations and drug conjugates; custom assembly of pharmaceuticals, biological preparations and drug conjugates; custom manufacturing of pharmaceuticals; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates |
| Goods and Services | Pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemico-pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; drugs for medical purposes, namely, anticancer preparations; biological preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicinal preparations for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; pharmaceutical preparations, substances and compositions for the prevention of cancer, infectious disease, metabolic disease, and central nervous system disease and conditions |
| Pseudo Mark | KUDO BIO TECHNOLOGY |
| NOT AVAILABLE | "BIOTECHNOLOGY" |
| Goods and Services | Scientific and engineering research services relating to the manufacture of biotechnology and pharmaceutical products; development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagents, pharmaceutical formulations, and biologics; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of nucleic acid medicines; research and development of mRNA drug substance and drug products; biomedical research services; development of pharmaceutical preparations and medicines |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 3, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 3, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 3, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | KUDO BIOTECHNOLOGY, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | NEEDHAM, MA 02494 |
| Party Name | RVAC Medicines Pte. Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Waltham, MA 02451 |
Trademark Events
| Event Date | Event Description |
| Thursday, July 6, 2023 | NEW APPLICATION ENTERED |
| Thursday, August 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 24, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, March 15, 2024 | ASSIGNED TO EXAMINER |
| Friday, March 22, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, March 22, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, March 22, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 24, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, June 24, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Monday, September 23, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 23, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 24, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 7, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, October 22, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, October 22, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 22, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 22, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 22, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, December 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
